Cargando…

Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model

Porcine circovirus type 2 (PCV2) is an economically important swine pathogen that causes porcine circovirus-associated diseases (PCVADs). The objective of this study was to evaluate the use of specific pathogen-free Yucatan miniature pigs (YMPs) as an experimental model for PCV2d challenge and vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Noh, Yun-Hee, Kim, Seung-Chai, Jeong, Chang-Gi, Lee, Seung-Chul, Lee, Dong-Uk, Yoon, In-Joong, Kim, Won-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501194/
https://www.ncbi.nlm.nih.gov/pubmed/36146547
http://dx.doi.org/10.3390/vaccines10091469
_version_ 1784795413946040320
author Noh, Yun-Hee
Kim, Seung-Chai
Jeong, Chang-Gi
Lee, Seung-Chul
Lee, Dong-Uk
Yoon, In-Joong
Kim, Won-Il
author_facet Noh, Yun-Hee
Kim, Seung-Chai
Jeong, Chang-Gi
Lee, Seung-Chul
Lee, Dong-Uk
Yoon, In-Joong
Kim, Won-Il
author_sort Noh, Yun-Hee
collection PubMed
description Porcine circovirus type 2 (PCV2) is an economically important swine pathogen that causes porcine circovirus-associated diseases (PCVADs). The objective of this study was to evaluate the use of specific pathogen-free Yucatan miniature pigs (YMPs) as an experimental model for PCV2d challenge and vaccine assessment because PCV2-negative pigs are extremely rare in conventional swine herds in Korea. In the first experiment, every three pigs were subjected to PCV2d field isolate or mock challenge. During three weeks of experiments, the PCV2d infection group exhibited clinical outcomes of PCVAD with high viral loads, lymphoid depletion, and detection of PCV2d antigens in lymphoid organs by immunohistochemistry. In the second experiment, three groups of pigs were challenged with PCV2d after immunization for three weeks: a nonvaccinated group (three pigs), a PCV2b-Vac group vaccinated with a commercial PCV2b-based inactivated vaccine SuiShot(®) Circo-ONE (five pigs), and a PCV2d-Vac group vaccinated with an experimental PCV2d-based inactivated vaccine (five pigs). During the three weeks of the challenge period, nonvaccinated pigs showed similar clinical outcomes to those observed in the PCV2d infection group from the first experiment. In contrast, both the PCV2b and PCV2d vaccinations produced good levels of protection against PCV2d challenge, as evidenced by reduced viral loads, improved growth performance, high virus-neutralizing antibody titers, and less development of PCV2-associated pathological lesions. Taken together, these data suggest that YMPs could be an alternative model for PCV2 challenge experiments, and these animals displayed typical clinical and pathological features and characteristics of protective immunity induced by the vaccines that were consistent with those resulting from PCV2 infections in conventional pigs.
format Online
Article
Text
id pubmed-9501194
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95011942022-09-24 Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model Noh, Yun-Hee Kim, Seung-Chai Jeong, Chang-Gi Lee, Seung-Chul Lee, Dong-Uk Yoon, In-Joong Kim, Won-Il Vaccines (Basel) Article Porcine circovirus type 2 (PCV2) is an economically important swine pathogen that causes porcine circovirus-associated diseases (PCVADs). The objective of this study was to evaluate the use of specific pathogen-free Yucatan miniature pigs (YMPs) as an experimental model for PCV2d challenge and vaccine assessment because PCV2-negative pigs are extremely rare in conventional swine herds in Korea. In the first experiment, every three pigs were subjected to PCV2d field isolate or mock challenge. During three weeks of experiments, the PCV2d infection group exhibited clinical outcomes of PCVAD with high viral loads, lymphoid depletion, and detection of PCV2d antigens in lymphoid organs by immunohistochemistry. In the second experiment, three groups of pigs were challenged with PCV2d after immunization for three weeks: a nonvaccinated group (three pigs), a PCV2b-Vac group vaccinated with a commercial PCV2b-based inactivated vaccine SuiShot(®) Circo-ONE (five pigs), and a PCV2d-Vac group vaccinated with an experimental PCV2d-based inactivated vaccine (five pigs). During the three weeks of the challenge period, nonvaccinated pigs showed similar clinical outcomes to those observed in the PCV2d infection group from the first experiment. In contrast, both the PCV2b and PCV2d vaccinations produced good levels of protection against PCV2d challenge, as evidenced by reduced viral loads, improved growth performance, high virus-neutralizing antibody titers, and less development of PCV2-associated pathological lesions. Taken together, these data suggest that YMPs could be an alternative model for PCV2 challenge experiments, and these animals displayed typical clinical and pathological features and characteristics of protective immunity induced by the vaccines that were consistent with those resulting from PCV2 infections in conventional pigs. MDPI 2022-09-05 /pmc/articles/PMC9501194/ /pubmed/36146547 http://dx.doi.org/10.3390/vaccines10091469 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Noh, Yun-Hee
Kim, Seung-Chai
Jeong, Chang-Gi
Lee, Seung-Chul
Lee, Dong-Uk
Yoon, In-Joong
Kim, Won-Il
Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model
title Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model
title_full Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model
title_fullStr Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model
title_full_unstemmed Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model
title_short Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model
title_sort pathological evaluation of porcine circovirus 2d (pcv2d) strain and comparative evaluation of pcv2d and pcv2b inactivated vaccines against pcv2d infection in a specific pathogen-free (spf) yucatan miniature pig model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501194/
https://www.ncbi.nlm.nih.gov/pubmed/36146547
http://dx.doi.org/10.3390/vaccines10091469
work_keys_str_mv AT nohyunhee pathologicalevaluationofporcinecircovirus2dpcv2dstrainandcomparativeevaluationofpcv2dandpcv2binactivatedvaccinesagainstpcv2dinfectioninaspecificpathogenfreespfyucatanminiaturepigmodel
AT kimseungchai pathologicalevaluationofporcinecircovirus2dpcv2dstrainandcomparativeevaluationofpcv2dandpcv2binactivatedvaccinesagainstpcv2dinfectioninaspecificpathogenfreespfyucatanminiaturepigmodel
AT jeongchanggi pathologicalevaluationofporcinecircovirus2dpcv2dstrainandcomparativeevaluationofpcv2dandpcv2binactivatedvaccinesagainstpcv2dinfectioninaspecificpathogenfreespfyucatanminiaturepigmodel
AT leeseungchul pathologicalevaluationofporcinecircovirus2dpcv2dstrainandcomparativeevaluationofpcv2dandpcv2binactivatedvaccinesagainstpcv2dinfectioninaspecificpathogenfreespfyucatanminiaturepigmodel
AT leedonguk pathologicalevaluationofporcinecircovirus2dpcv2dstrainandcomparativeevaluationofpcv2dandpcv2binactivatedvaccinesagainstpcv2dinfectioninaspecificpathogenfreespfyucatanminiaturepigmodel
AT yooninjoong pathologicalevaluationofporcinecircovirus2dpcv2dstrainandcomparativeevaluationofpcv2dandpcv2binactivatedvaccinesagainstpcv2dinfectioninaspecificpathogenfreespfyucatanminiaturepigmodel
AT kimwonil pathologicalevaluationofporcinecircovirus2dpcv2dstrainandcomparativeevaluationofpcv2dandpcv2binactivatedvaccinesagainstpcv2dinfectioninaspecificpathogenfreespfyucatanminiaturepigmodel